Armata Pharmaceuticals Files 8-K

Ticker: ARMP · Form: 8-K · Filed: May 1, 2025 · CIK: 921114

Armata Pharmaceuticals, INC. 8-K Filing Summary
FieldDetail
CompanyArmata Pharmaceuticals, INC. (ARMP)
Form Type8-K
Filed DateMay 1, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-K, filing, corporate-update

TL;DR

Armata Pharma filed an 8-K on May 1st, standard reporting.

AI Summary

Armata Pharmaceuticals, Inc. filed an 8-K on May 1, 2025, reporting other events and financial statements. The company, formerly known as AmpliPhi Biosciences Corp and Targeted Genetics Corp, is incorporated in Washington and headquartered in Los Angeles, California.

Why It Matters

This filing indicates a routine update or event for Armata Pharmaceuticals, Inc., providing transparency to investors about the company's operational status and financial reporting.

Risk Assessment

Risk Level: low — This is a routine 8-K filing for reporting events and financial statements, not indicating any immediate significant risk.

Key Numbers

Key Players & Entities

FAQ

What specific 'Other Events' are being reported in this 8-K filing?

The provided text does not detail the specific 'Other Events' beyond stating that this item is being reported.

What is the significance of the former company names 'AmpliPhi Biosciences Corp' and 'Targeted Genetics Corp /WA/'?

These are former names of Armata Pharmaceuticals, Inc., indicating a history of corporate name changes or mergers.

What is the primary business of Armata Pharmaceuticals, Inc. according to the SIC code?

The Standard Industrial Classification (SIC) code [2836] indicates the company is in the 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' industry.

When was Armata Pharmaceuticals, Inc. incorporated or organized?

The filing states the company is incorporated or organized in 'Washington'.

What is the fiscal year end for Armata Pharmaceuticals, Inc.?

The fiscal year end for Armata Pharmaceuticals, Inc. is December 31st (1231).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 1, 2025 regarding Armata Pharmaceuticals, Inc. (ARMP).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing